Allopurinol Tablet
Product Images NDC 51655-523

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 51655-523). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 523 52)

Label for Allopurinol Tablets USP 100 mg oral tablets, packaged as 30 tablets per container. The label includes storage instructions at 20°-25°C, cautions to keep out of reach of children, and indicates prescription-only status. The product is repackaged by Northwind Pharmaceuticals, Indianapolis, IN.*

FDA Label Image

Figure (Allopurinol Fig 1)

Chemical structure diagram showing the metabolic conversion pathways between Allopurinol, Oxipurinol, Hypoxanthine, Xanthine, and Uric Acid. Each compound's chemical name is labeled alongside its corresponding molecular structure.*

FDA Label Image

Structural Formula (Allopurinol Structure)

Chemical structure of allopurinol, showing a purine-like fused ring system with nitrogen and oxygen atoms, including an amide group and an imidazole ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.